APA

Mann G. J., Pupo G. M., Campain A. E., Carter C. D., Schramm S., Pianova S., Gerega S. K., De Silva C., Lai K., Wilmott J. S., Synnott M., Hersey P., Kefford R. F., Thompson J. F., Yang Y. H. & Scolyer R. A. (20130312). BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. : The Journal of investigative dermatology.

Chicago

Mann Graham J, Pupo Gulietta M, Campain Anna E, Carter Candace D, Schramm Sarah-Jane, Pianova Svetlana, Gerega Sebastien K, De Silva Chitra, Lai Kenneth, Wilmott James S, Synnott Maria, Hersey Peter, Kefford Richard F, Thompson John F, Yang Yee Hwa and Scolyer Richard A. 20130312. BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. : The Journal of investigative dermatology.

Harvard

Mann G. J., Pupo G. M., Campain A. E., Carter C. D., Schramm S., Pianova S., Gerega S. K., De Silva C., Lai K., Wilmott J. S., Synnott M., Hersey P., Kefford R. F., Thompson J. F., Yang Y. H. and Scolyer R. A. (20130312). BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. : The Journal of investigative dermatology.

MLA

Mann Graham J, Pupo Gulietta M, Campain Anna E, Carter Candace D, Schramm Sarah-Jane, Pianova Svetlana, Gerega Sebastien K, De Silva Chitra, Lai Kenneth, Wilmott James S, Synnott Maria, Hersey Peter, Kefford Richard F, Thompson John F, Yang Yee Hwa and Scolyer Richard A. BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. : The Journal of investigative dermatology. 20130312.